Participants were randomly assigned, 1:1:1, to once-weekly combination cagrilintide and semaglutide 2.4 mg, once-weekly semaglutide 2.4 mg plus placebo or once-weekly cagrilintide 2.4 mg plus placebo
Nat Commun 9(1):4462 Nakamoto N, Sasaki N, Aoki R, Miyamoto K, Suda W, Teratani T et al (2019) Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis
Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use
Acknowledging unknowns
Scaling concepts in omics: Nuclear lamin-B scales with tumor growth and often predicts poor prognosis, unlike fibrosis